EP Patent

EP1231219A1 — GLucagon-like peptide-2 analogs

Assigned to 1149336 Ontario Inc · Expires 2002-08-14 · 24y expired

What this patent protects

Analogs of glucagon-like peptide-2, a product of glucagon gene expression, have been identified as intestinal tissue growth factors. Their formulation as pharmaceutical and therapeutic use in treating disorders of the small bowel are described.

USPTO Abstract

Analogs of glucagon-like peptide-2, a product of glucagon gene expression, have been identified as intestinal tissue growth factors. Their formulation as pharmaceutical and therapeutic use in treating disorders of the small bowel are described.

Drugs covered by this patent

Patent Metadata

Patent number
EP1231219A1
Jurisdiction
EP
Classification
—
Expires
2002-08-14
Drug substance claim
No
Drug product claim
No
Assignee
1149336 Ontario Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.